Muroyama Y, Miura C, Imai Y, Suzuki T
Int J Surg Case Rep. 2024; 122:110151.
PMID: 39128214
PMC: 11367090.
DOI: 10.1016/j.ijscr.2024.110151.
Ji K, Schwenkel G, Mattingly R, Sundararaghavan H, Zhang Z, Chopp M
Cancers (Basel). 2024; 16(14).
PMID: 39061138
PMC: 11274591.
DOI: 10.3390/cancers16142498.
White E, Rhodes S
Cancers (Basel). 2024; 16(5).
PMID: 38473354
PMC: 10930863.
DOI: 10.3390/cancers16050994.
Lakes Y, Moye S, Mo J, Tegtmeyer M, Nehme R, Charlton M
Cell Rep Med. 2023; 4(12):101309.
PMID: 38086379
PMC: 10772348.
DOI: 10.1016/j.xcrm.2023.101309.
Noureldine M, Shimony N, Jallo G
Adv Exp Med Biol. 2023; 1405:583-606.
PMID: 37452955
DOI: 10.1007/978-3-031-23705-8_23.
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
Staedtke V, Topilko P, Le L, Grimes K, Largaespada D, Cagan R
J Invest Dermatol. 2023; 143(8):1378-1387.
PMID: 37330719
PMC: 11246562.
DOI: 10.1016/j.jid.2023.01.042.
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C, McKay R, Lee S, Romo C, Blakeley J, Haniffa M
J Invest Dermatol. 2023; 143(8):1369-1377.
PMID: 37318402
PMC: 11173230.
DOI: 10.1016/j.jid.2022.12.027.
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.
Suppiah S, Mansouri S, Mamatjan Y, Liu J, Bhunia M, Patil V
Nat Commun. 2023; 14(1):2696.
PMID: 37164978
PMC: 10172395.
DOI: 10.1038/s41467-023-38432-6.
Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.
Jiang C, Kumar A, Yu Z, Shipman T, Wang Y, McKay R
J Clin Invest. 2023; 133(12).
PMID: 37140985
PMC: 10266775.
DOI: 10.1172/JCI168227.
Mediastinal Teratoma Mimicking Neurofibroma in CT-Guided Biopsy in a Patient With Neurofibromatosis Type 1.
Gkikas A, Mitsos S, Antonopoulos A, Korodimos N, Santaitidis E, Koufopoulos N
Cureus. 2023; 15(3):e36562.
PMID: 37095824
PMC: 10122137.
DOI: 10.7759/cureus.36562.
Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.
Ge L, Xing M, Zhang H, Wang Z
Cancers (Basel). 2022; 14(18).
PMID: 36139671
PMC: 9497298.
DOI: 10.3390/cancers14184513.
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.
Yan J, Chen Y, Patel A, Warda S, Lee C, Nixon B
J Clin Invest. 2022; 132(17).
PMID: 35852856
PMC: 9433107.
DOI: 10.1172/JCI153437.
Superimposition of checkerboard distribution of ephelides and neurofibromas in a patient with segmental neurofibromatosis.
Iriki H, Umegaki-Arao N, Kakuta R, Fujita H, Aoki S, Amagai M
JAAD Case Rep. 2022; 25:89-92.
PMID: 35799684
PMC: 9253525.
DOI: 10.1016/j.jdcr.2022.05.025.
Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.
Anastasaki C, Mo J, Chen J, Chatterjee J, Pan Y, Scheaffer S
Nat Commun. 2022; 13(1):2785.
PMID: 35589737
PMC: 9120229.
DOI: 10.1038/s41467-022-30466-6.
RAS and beyond: the many faces of the neurofibromatosis type 1 protein.
Anastasaki C, Orozco P, Gutmann D
Dis Model Mech. 2022; 15(2).
PMID: 35188187
PMC: 8891636.
DOI: 10.1242/dmm.049362.
Insights into the Pathogenesis of NF1-Associated Neoplasms.
Bui A, Jiang C, McKay R, Klesse L, Le L
JID Innov. 2021; 1(3).
PMID: 34604833
PMC: 8486282.
DOI: 10.1016/j.xjidi.2021.100044.
Irradiation of mutant mouse models of spinal plexiform neurofibromas drives pathologic progression and decreases survival.
Laurent D, Smith A, Bessler W, Mendonca M, Chin-Sinex H, Descovich M
Neurooncol Adv. 2021; 3(1):vdab063.
PMID: 34131650
PMC: 8193912.
DOI: 10.1093/noajnl/vdab063.
Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D, Xie X, Zhang X, Wang Z, Farouk Sait S, Iyer S
Cell Stem Cell. 2021; 28(8):1397-1410.e4.
PMID: 34010628
PMC: 8349880.
DOI: 10.1016/j.stem.2021.04.029.
A giant posterior mediastinal malignant peripheral nerve sheath tumor and benign neurofibroma in body surface: a case report.
Zhang Y, Cai H, Lv G, Li Y
BMC Surg. 2021; 21(1):128.
PMID: 33691671
PMC: 7945373.
DOI: 10.1186/s12893-021-01122-5.
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
Osum S, Watson A, Largaespada D
Int J Mol Sci. 2021; 22(4).
PMID: 33669386
PMC: 7920315.
DOI: 10.3390/ijms22041954.